DonaldBertramChalfinMDMS, MPH, FCCP, FCCM

Internal Medicine • Berkeley, CA

Critical Care Medicine, Healthcare Research and Healthcare Policy

Clinical Expert, Siemens Healthineers

Join to view full profile

Dr. Chalfin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chalfin's full profile

Already have an account?

Office
1749 Sonoma Avenue
Berkeley, CA 94707
Phone+1 516-448-0047

Education & Training

John Hopkins University: The Bloomberg School of Public HealthMPH, 2011 - 2014
NYU: Robert F. Wagner Graduate School of Public HealthMS, Health Management, 1988 - 1991
Memorial Sloan Kettering Cancer CenterFellowship, Critical Care Medicine (Internal Medicine), 1988 - 1990
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1985 - 1988
Icahn School of Medicine at Mount SinaiClass of 1985

Certifications & Licensure

OH State Medical License Current
CA State Medical License 2014 - 2026
NY State Medical License 1987 - 2026
TX State Medical License 2022 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine

Awards, Honors, & Recognition

Fellow (FCCP) American College of Chest Physicians
Fellow (FCCM) American College of Critical Care Medicine

Publications & Presentations

PubMed

Comparison of Referral Rates and Costs Using Fibrosis-4 and Enhanced Liver Fibrosis (ELF) Testing Strategies for Initial Evaluation of Metabolic Dysfunction-Associated...
Samrat Yeramaneni, Stephanie T Chang, Ramsey C Cheung, Donald B Chalfin, Kinpritma Sangha
The Journal of Applied Laboratory Medicine. 2025-01-15
A Palace With a Common Tongue or a Multivariate Tower of Babel?
Donald B Chalfin, Andrew A Kramer
Critical Care Medicine. 2022-07-01
15 citations
A Deep Learning Approach for Predicting Severity of COVID-19 Patients Using a Parsimonious Set of Laboratory Markers
Vivek Kumar Singh, Rishikesan Kamaleswaran, Donald Chalfin, Antonio Buño-Soto, Janika San Roman
Iscience. 2021-05-25

Professional Memberships

Industry Relationships

Consultant, Theravance2014 - Present
Medical Director, Abbott Laboratories2007 - 2014